Suchergebnisse - "Goeckenjan, Maren"

PubPharm (64)

51

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

enthalten in: Phytomedicine : international journal of phytotherapy and phytopharmacology | 2019

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +9

52

Concept Paper on the Technique of Cryopreservation, Removal and Transplantation of Ovarian Tissue for Fertility Preservation

enthalten in: Geburtshilfe und Frauenheilkunde | 2019

von Beckmann, M. | Lotz, L. | Toth, B. | +23

53

Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2)

enthalten in: Phytomedicine | 2019

von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +8

54

Fertility Preservation for Patients with Malignant Disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) - Recommendations and Statements for Girls and Women

enthalten in: Geburtshilfe und Frauenheilkunde | 2018

von Dittrich, R. | Kliesch, S. | Schüring, A. | +54

55

Fertility preservation for watients with malignant disease. Guideline of the DGGG, DGU and DGRM (S2k-Level, AWMF Registry No. 015/082, November 2017) : recommendations and statements for girls and women

enthalten in: Geburtshilfe und Frauenheilkunde | 2018

von Dittrich, R. | Kliesch, S. | Balcerek, M. | +34

56

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

57

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

58

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

59

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 2017

von von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +10

60

Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

enthalten in: Breast cancer research and treatment | 24 April 2017

von Hagens, C. | Walter-Sack, I. | Goeckenjan, M. | +9